aluates Reports

$ 0.0

Automative

Global Recombinant Protein Drug R & D Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-9C6045

Global Recombinant Protein Drug R D Market Insights Forecast to 2028

BUY CHAPTERS

Global Recombinant Protein Drug R & D Market Research Report 2024

Code: QYRE-Auto-9C6045

Report

February 2024

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly

Novo Nordisk

Amgen Inc

Merck

Sanofi

Pfizer Inc

Roche

GenSci

Ankebio

United Cell

Sinobioway Hygene

Kexing

Dongbao

3SBio Inc

Gan & Lee

Hengrui

Recombinant Protein Drug R & D Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Recombinant Protein Drug R & D Market

The global Recombinant Protein Drug R & D market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The global recombinant protein drug R&D market is expected to witness substantial growth due to the increasing demand for targeted and personalized therapies, advancements in biotechnology, and ongoing efforts to address unmet medical needs. The market will continue to evolve as new discoveries are made and innovative therapeutic strategies emerge from ongoing research and development activities.

This report aims to provide a comprehensive presentation of the global market for Recombinant Protein Drug R & D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein Drug R & D.

Report Scope

The Recombinant Protein Drug R & D market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Protein Drug R & D market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Protein Drug R & D companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Recombinant Protein Drug R & D Market Report

Report Metric	Details
Report Name	Recombinant Protein Drug R & D Market
CAGR	5%
Segment by Type	Peptide Hormones Hematopoietic Factor Cytokines Plasma Protein Factor Recombinase Fusion Protein Other
Segment by Application	Diabetes Dwarfism Hemophilia Heart Disease Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eli Lilly, Novo Nordisk, Amgen, Merck, Sanofi, Pfizer, Roche, Gensci, Ankebio, United Cell, Sinobioway Hygene, Kexing, Dongbao, 3sbio, Gan&Lee, Hengrui
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Drug R & D companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Protein Drug R & D Market report?

Ans: The main players in the Recombinant Protein Drug R & D Market are Eli Lilly, Novo Nordisk, Amgen, Merck, Sanofi, Pfizer, Roche, Gensci, Ankebio, United Cell, Sinobioway Hygene, Kexing, Dongbao, 3sbio, Gan&Lee, Hengrui

What are the Application segmentation covered in the Recombinant Protein Drug R & D Market report?

Ans: The Applications covered in the Recombinant Protein Drug R & D Market report are Diabetes, Dwarfism, Hemophilia, Heart Disease, Cancer, Other

What are the Type segmentation covered in the Recombinant Protein Drug R & D Market report?

Ans: The Types covered in the Recombinant Protein Drug R & D Market report are Peptide Hormones, Hematopoietic Factor, Cytokines, Plasma Protein Factor, Recombinase, Fusion Protein, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Recombinant Protein Drug R & D Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Peptide Hormones

1.2.3 Hematopoietic Factor

1.2.4 Cytokines

1.2.5 Plasma Protein Factor

1.2.6 Recombinase

1.2.7 Fusion Protein

1.2.8 Other

1.3 Market by Application

1.3.1 Global Recombinant Protein Drug R & D Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Diabetes

1.3.3 Dwarfism

1.3.4 Hemophilia

1.3.5 Heart Disease

1.3.6 Cancer

1.3.7 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Recombinant Protein Drug R & D Market Perspective (2019-2030)

2.2 Recombinant Protein Drug R & D Growth Trends by Region

2.2.1 Global Recombinant Protein Drug R & D Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Recombinant Protein Drug R & D Historic Market Size by Region (2019-2024)

2.2.3 Recombinant Protein Drug R & D Forecasted Market Size by Region (2025-2030)

2.3 Recombinant Protein Drug R & D Market Dynamics

2.3.1 Recombinant Protein Drug R & D Industry Trends

2.3.2 Recombinant Protein Drug R & D Market Drivers

2.3.3 Recombinant Protein Drug R & D Market Challenges

2.3.4 Recombinant Protein Drug R & D Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Recombinant Protein Drug R & D Players by Revenue

3.1.1 Global Top Recombinant Protein Drug R & D Players by Revenue (2019-2024)

3.1.2 Global Recombinant Protein Drug R & D Revenue Market Share by Players (2019-2024)

3.2 Global Recombinant Protein Drug R & D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Recombinant Protein Drug R & D Revenue

3.4 Global Recombinant Protein Drug R & D Market Concentration Ratio

3.4.1 Global Recombinant Protein Drug R & D Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Drug R & D Revenue in 2023

3.5 Recombinant Protein Drug R & D Key Players Head office and Area Served

3.6 Key Players Recombinant Protein Drug R & D Product Solution and Service

3.7 Date of Enter into Recombinant Protein Drug R & D Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant Protein Drug R & D Breakdown Data by Type

4.1 Global Recombinant Protein Drug R & D Historic Market Size by Type (2019-2024)

4.2 Global Recombinant Protein Drug R & D Forecasted Market Size by Type (2025-2030)

5 Recombinant Protein Drug R & D Breakdown Data by Application

5.1 Global Recombinant Protein Drug R & D Historic Market Size by Application (2019-2024)

5.2 Global Recombinant Protein Drug R & D Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Recombinant Protein Drug R & D Market Size (2019-2030)

6.2 North America Recombinant Protein Drug R & D Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Recombinant Protein Drug R & D Market Size by Country (2019-2024)

6.4 North America Recombinant Protein Drug R & D Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Recombinant Protein Drug R & D Market Size (2019-2030)

7.2 Europe Recombinant Protein Drug R & D Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Recombinant Protein Drug R & D Market Size by Country (2019-2024)

7.4 Europe Recombinant Protein Drug R & D Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Recombinant Protein Drug R & D Market Size (2019-2030)

8.2 Asia-Pacific Recombinant Protein Drug R & D Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Recombinant Protein Drug R & D Market Size by Region (2019-2024)

8.4 Asia-Pacific Recombinant Protein Drug R & D Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Recombinant Protein Drug R & D Market Size (2019-2030)

9.2 Latin America Recombinant Protein Drug R & D Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Recombinant Protein Drug R & D Market Size by Country (2019-2024)

9.4 Latin America Recombinant Protein Drug R & D Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Recombinant Protein Drug R & D Market Size (2019-2030)

10.2 Middle East & Africa Recombinant Protein Drug R & D Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Recombinant Protein Drug R & D Market Size by Country (2019-2024)

10.4 Middle East & Africa Recombinant Protein Drug R & D Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Company Detail

11.1.2 Eli Lilly Business Overview

11.1.3 Eli Lilly Recombinant Protein Drug R & D Introduction

11.1.4 Eli Lilly Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.1.5 Eli Lilly Recent Development

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Detail

11.2.2 Novo Nordisk Business Overview

11.2.3 Novo Nordisk Recombinant Protein Drug R & D Introduction

11.2.4 Novo Nordisk Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.2.5 Novo Nordisk Recent Development

11.3 Amgen

11.3.1 Amgen Company Detail

11.3.2 Amgen Business Overview

11.3.3 Amgen Recombinant Protein Drug R & D Introduction

11.3.4 Amgen Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.3.5 Amgen Recent Development

11.4 Merck

11.4.1 Merck Company Detail

11.4.2 Merck Business Overview

11.4.3 Merck Recombinant Protein Drug R & D Introduction

11.4.4 Merck Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.4.5 Merck Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Recombinant Protein Drug R & D Introduction

11.5.4 Sanofi Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.5.5 Sanofi Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Detail

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Recombinant Protein Drug R & D Introduction

11.6.4 Pfizer Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.6.5 Pfizer Recent Development

11.7 Roche

11.7.1 Roche Company Detail

11.7.2 Roche Business Overview

11.7.3 Roche Recombinant Protein Drug R & D Introduction

11.7.4 Roche Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.7.5 Roche Recent Development

11.8 Gensci

11.8.1 Gensci Company Detail

11.8.2 Gensci Business Overview

11.8.3 Gensci Recombinant Protein Drug R & D Introduction

11.8.4 Gensci Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.8.5 Gensci Recent Development

11.9 Ankebio

11.9.1 Ankebio Company Detail

11.9.2 Ankebio Business Overview

11.9.3 Ankebio Recombinant Protein Drug R & D Introduction

11.9.4 Ankebio Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.9.5 Ankebio Recent Development

11.10 United Cell

11.10.1 United Cell Company Detail

11.10.2 United Cell Business Overview

11.10.3 United Cell Recombinant Protein Drug R & D Introduction

11.10.4 United Cell Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.10.5 United Cell Recent Development

11.11 Sinobioway Hygene

11.11.1 Sinobioway Hygene Company Detail

11.11.2 Sinobioway Hygene Business Overview

11.11.3 Sinobioway Hygene Recombinant Protein Drug R & D Introduction

11.11.4 Sinobioway Hygene Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.11.5 Sinobioway Hygene Recent Development

11.12 Kexing

11.12.1 Kexing Company Detail

11.12.2 Kexing Business Overview

11.12.3 Kexing Recombinant Protein Drug R & D Introduction

11.12.4 Kexing Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.12.5 Kexing Recent Development

11.13 Dongbao

11.13.1 Dongbao Company Detail

11.13.2 Dongbao Business Overview

11.13.3 Dongbao Recombinant Protein Drug R & D Introduction

11.13.4 Dongbao Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.13.5 Dongbao Recent Development

11.14 3sbio

11.14.1 3sbio Company Detail

11.14.2 3sbio Business Overview

11.14.3 3sbio Recombinant Protein Drug R & D Introduction

11.14.4 3sbio Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.14.5 3sbio Recent Development

11.15 Gan&Lee

11.15.1 Gan&Lee Company Detail

11.15.2 Gan&Lee Business Overview

11.15.3 Gan&Lee Recombinant Protein Drug R & D Introduction

11.15.4 Gan&Lee Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.15.5 Gan&Lee Recent Development

11.16 Hengrui

11.16.1 Hengrui Company Detail

11.16.2 Hengrui Business Overview

11.16.3 Hengrui Recombinant Protein Drug R & D Introduction

11.16.4 Hengrui Revenue in Recombinant Protein Drug R & D Business (2019-2024)

11.16.5 Hengrui Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Eli Lilly

Novo Nordisk

Amgen Inc

Merck

Sanofi

Pfizer Inc

Roche

GenSci

Ankebio

United Cell

Sinobioway Hygene

Kexing

Dongbao

3SBio Inc

Gan & Lee

Hengrui

List of Tables

Table 1. Global Recombinant Protein Drug R & D Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Peptide Hormones

Table 3. Key Players of Hematopoietic Factor

Table 4. Key Players of Cytokines

Table 5. Key Players of Plasma Protein Factor

Table 6. Key Players of Recombinase

Table 7. Key Players of Fusion Protein

Table 8. Key Players of Other

Table 9. Global Recombinant Protein Drug R & D Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Recombinant Protein Drug R & D Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Recombinant Protein Drug R & D Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Recombinant Protein Drug R & D Market Share by Region (2019-2024)

Table 13. Global Recombinant Protein Drug R & D Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Recombinant Protein Drug R & D Market Share by Region (2025-2030)

Table 15. Recombinant Protein Drug R & D Market Trends

Table 16. Recombinant Protein Drug R & D Market Drivers

Table 17. Recombinant Protein Drug R & D Market Challenges

Table 18. Recombinant Protein Drug R & D Market Restraints

Table 19. Global Recombinant Protein Drug R & D Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Recombinant Protein Drug R & D Market Share by Players (2019-2024)

Table 21. Global Top Recombinant Protein Drug R & D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Drug R & D as of 2023)

Table 22. Ranking of Global Top Recombinant Protein Drug R & D Companies by Revenue (US$ Million) in 2023

Table 23. Global 5 Largest Players Market Share by Recombinant Protein Drug R & D Revenue (CR5 and HHI) & (2019-2024)

Table 24. Key Players Headquarters and Area Served

Table 25. Key Players Recombinant Protein Drug R & D Product Solution and Service

Table 26. Date of Enter into Recombinant Protein Drug R & D Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Recombinant Protein Drug R & D Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Recombinant Protein Drug R & D Revenue Market Share by Type (2019-2024)

Table 30. Global Recombinant Protein Drug R & D Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Recombinant Protein Drug R & D Revenue Market Share by Type (2025-2030)

Table 32. Global Recombinant Protein Drug R & D Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Recombinant Protein Drug R & D Revenue Market Share by Application (2019-2024)

Table 34. Global Recombinant Protein Drug R & D Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Recombinant Protein Drug R & D Revenue Market Share by Application (2025-2030)

Table 36. North America Recombinant Protein Drug R & D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Recombinant Protein Drug R & D Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Recombinant Protein Drug R & D Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Recombinant Protein Drug R & D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Europe Recombinant Protein Drug R & D Market Size by Country (2019-2024) & (US$ Million)

Table 41. Europe Recombinant Protein Drug R & D Market Size by Country (2025-2030) & (US$ Million)

Table 42. Asia-Pacific Recombinant Protein Drug R & D Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 43. Asia-Pacific Recombinant Protein Drug R & D Market Size by Region (2019-2024) & (US$ Million)

Table 44. Asia-Pacific Recombinant Protein Drug R & D Market Size by Region (2025-2030) & (US$ Million)

Table 45. Latin America Recombinant Protein Drug R & D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Latin America Recombinant Protein Drug R & D Market Size by Country (2019-2024) & (US$ Million)

Table 47. Latin America Recombinant Protein Drug R & D Market Size by Country (2025-2030) & (US$ Million)

Table 48. Middle East & Africa Recombinant Protein Drug R & D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Middle East & Africa Recombinant Protein Drug R & D Market Size by Country (2019-2024) & (US$ Million)

Table 50. Middle East & Africa Recombinant Protein Drug R & D Market Size by Country (2025-2030) & (US$ Million)

Table 51. Eli Lilly Company Detail

Table 52. Eli Lilly Business Overview

Table 53. Eli Lilly Recombinant Protein Drug R & D Product

Table 54. Eli Lilly Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 55. Eli Lilly Recent Development

Table 56. Novo Nordisk Company Detail

Table 57. Novo Nordisk Business Overview

Table 58. Novo Nordisk Recombinant Protein Drug R & D Product

Table 59. Novo Nordisk Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 60. Novo Nordisk Recent Development

Table 61. Amgen Company Detail

Table 62. Amgen Business Overview

Table 63. Amgen Recombinant Protein Drug R & D Product

Table 64. Amgen Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 65. Amgen Recent Development

Table 66. Merck Company Detail

Table 67. Merck Business Overview

Table 68. Merck Recombinant Protein Drug R & D Product

Table 69. Merck Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 70. Merck Recent Development

Table 71. Sanofi Company Detail

Table 72. Sanofi Business Overview

Table 73. Sanofi Recombinant Protein Drug R & D Product

Table 74. Sanofi Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 75. Sanofi Recent Development

Table 76. Pfizer Company Detail

Table 77. Pfizer Business Overview

Table 78. Pfizer Recombinant Protein Drug R & D Product

Table 79. Pfizer Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 80. Pfizer Recent Development

Table 81. Roche Company Detail

Table 82. Roche Business Overview

Table 83. Roche Recombinant Protein Drug R & D Product

Table 84. Roche Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 85. Roche Recent Development

Table 86. Gensci Company Detail

Table 87. Gensci Business Overview

Table 88. Gensci Recombinant Protein Drug R & D Product

Table 89. Gensci Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 90. Gensci Recent Development

Table 91. Ankebio Company Detail

Table 92. Ankebio Business Overview

Table 93. Ankebio Recombinant Protein Drug R & D Product

Table 94. Ankebio Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 95. Ankebio Recent Development

Table 96. United Cell Company Detail

Table 97. United Cell Business Overview

Table 98. United Cell Recombinant Protein Drug R & D Product

Table 99. United Cell Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 100. United Cell Recent Development

Table 101. Sinobioway Hygene Company Detail

Table 102. Sinobioway Hygene Business Overview

Table 103. Sinobioway Hygene Recombinant Protein Drug R & D Product

Table 104. Sinobioway Hygene Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 105. Sinobioway Hygene Recent Development

Table 106. Kexing Company Detail

Table 107. Kexing Business Overview

Table 108. Kexing Recombinant Protein Drug R & D Product

Table 109. Kexing Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 110. Kexing Recent Development

Table 111. Dongbao Company Detail

Table 112. Dongbao Business Overview

Table 113. Dongbao Recombinant Protein Drug R & D Product

Table 114. Dongbao Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 115. Dongbao Recent Development

Table 116. 3sbio Company Detail

Table 117. 3sbio Business Overview

Table 118. 3sbio Recombinant Protein Drug R & D Product

Table 119. 3sbio Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 120. 3sbio Recent Development

Table 121. Gan&Lee Company Detail

Table 122. Gan&Lee Business Overview

Table 123. Gan&Lee Recombinant Protein Drug R & D Product

Table 124. Gan&Lee Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 125. Gan&Lee Recent Development

Table 126. Hengrui Company Detail

Table 127. Hengrui Business Overview

Table 128. Hengrui Recombinant Protein Drug R & D Product

Table 129. Hengrui Revenue in Recombinant Protein Drug R & D Business (2019-2024) & (US$ Million)

Table 130. Hengrui Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Recombinant Protein Drug R & D Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Recombinant Protein Drug R & D Market Share by Type: 2023 VS 2030

Figure 3. Peptide Hormones Features

Figure 4. Hematopoietic Factor Features

Figure 5. Cytokines Features

Figure 6. Plasma Protein Factor Features

Figure 7. Recombinase Features

Figure 8. Fusion Protein Features

Figure 9. Other Features

Figure 10. Global Recombinant Protein Drug R & D Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Recombinant Protein Drug R & D Market Share by Application: 2023 VS 2030

Figure 12. Diabetes Case Studies

Figure 13. Dwarfism Case Studies

Figure 14. Hemophilia Case Studies

Figure 15. Heart Disease Case Studies

Figure 16. Cancer Case Studies

Figure 17. Other Case Studies

Figure 18. Recombinant Protein Drug R & D Report Years Considered

Figure 19. Global Recombinant Protein Drug R & D Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 20. Global Recombinant Protein Drug R & D Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 21. Global Recombinant Protein Drug R & D Market Share by Region: 2023 VS 2030

Figure 22. Global Recombinant Protein Drug R & D Market Share by Players in 2023

Figure 23. Global Top Recombinant Protein Drug R & D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Drug R & D as of 2023)

Figure 24. The Top 10 and 5 Players Market Share by Recombinant Protein Drug R & D Revenue in 2023

Figure 25. North America Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. North America Recombinant Protein Drug R & D Market Share by Country (2019-2030)

Figure 27. United States Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Canada Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Europe Recombinant Protein Drug R & D Market Share by Country (2019-2030)

Figure 31. Germany Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia-Pacific Recombinant Protein Drug R & D Market Share by Region (2019-2030)

Figure 39. China Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Japan Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. India Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Australia Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Latin America Recombinant Protein Drug R & D Market Share by Country (2019-2030)

Figure 47. Mexico Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Brazil Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Recombinant Protein Drug R & D Market Share by Country (2019-2030)

Figure 51. Turkey Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Recombinant Protein Drug R & D Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Eli Lilly Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 54. Novo Nordisk Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 55. Amgen Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 56. Merck Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 57. Sanofi Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 58. Pfizer Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 59. Roche Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 60. Gensci Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 61. Ankebio Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 62. United Cell Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 63. Sinobioway Hygene Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 64. Kexing Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 65. Dongbao Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 66. 3sbio Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 67. Gan&Lee Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 68. Hengrui Revenue Growth Rate in Recombinant Protein Drug R & D Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Recombinant Protein Drugs Market

Recombinant Glycosylated Proteins Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceuticals and Biotechnology R D Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Protein Therapeutics Market

Global Recombinant Protein Reagents Market Research Report 2025

Global Retinal Disorder Treatment Market Research Report 2024

Global Combination Therapy Drug Market Research Report 2025

Global Still s Disease Treatment Market Research Report 2025

Constrained Peptide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Research Report 2024

Global Next Generation Antibody Drug Market Research Report 2024

Global Innovative Medicine Market Research Report 2024

Global Treatment Planning Software Market Research Report 2025

Global Autoimmune Diseases Treatment Market Research Report 2024

Global Recurrent Glioblastoma Multiforme Treatment Market Research Report 2025

Global Pharmaceutical Validation Services Market Research Report 2025

Genetically Engineered Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Complement Drug Market Research Report 2024

New Drug Research and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions